Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 8.07% vs 17.28% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is 22.52% vs -2.24% in Mar 2025
Investments
YoY Growth in year ended Mar 2026 is 1.74% vs 17.81% in Mar 2025
Current Assets
YoY Growth in year ended Mar 2026 is 0.42% vs 0.77% in Mar 2025
Compare Balance Sheet Results of Samrat Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
3.09
15.25
-12.16
-79.74%
Share Warrants & Outstandings
Total Reserve
65.09
13.12
51.97
396.11%
Shareholder's Funds
68.18
28.37
39.81
140.32%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
0.41
0.13
0.28
215.38%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
0.41
0.13
0.28
215.38%
Current Liabilities
Trade Payables
42.83
3.35
39.48
1,178.51%
Other Current Liabilities
2.28
2.88
-0.60
-20.83%
Short Term Borrowings
10.71
0.21
10.50
5,000.00%
Short Term Provisions
0.00
0.00
0.00
0.00%
Total Current Liabilities
55.82
6.44
49.38
766.77%
Total Liabilities
124.42
34.94
89.48
256.10%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
18.80
11.26
7.54
66.96%
Less: Accumulated Depreciation
7.08
8.39
-1.31
-15.61%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
11.71
2.87
8.84
308.01%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.12
0.00
1.12
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
3.50
0.00
3.50
0.00%
Long Term Loans & Advances
0.83
0.00
0.83
0.00%
Other Non Current Assets
3.46
4.69
-1.23
-26.23%
Total Non-Current Assets
20.63
7.56
13.07
172.88%
Current Assets Loans & Advances
Current Investments
0.37
0.00
0.37
0.00%
Inventories
43.62
7.22
36.40
504.16%
Sundry Debtors
51.05
15.96
35.09
219.86%
Cash and Bank
6.00
1.47
4.53
308.16%
Other Current Assets
0.11
2.31
-2.20
-95.24%
Short Term Loans and Advances
2.64
0.43
2.21
513.95%
Total Current Assets
103.79
27.38
76.41
279.07%
Net Current Assets (Including Current Investments)
47.96
20.94
27.02
129.04%
Total Current Assets Excluding Current Investments
103.42
27.38
76.04
277.72%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
124.42
34.94
89.48
256.10%
Contingent Liabilities
0.91
0.00
0.91
0.00%
Total Debt
10.71
0.21
10.50
5,000.00%
Book Value per share (adjusted)
220.67
18.60
202.07
1,086.40%
Annual - Borrowings
Borrowings 10.71 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 8.07% vs 17.28% in Mar 2025
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 12.84 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 22.52% vs -2.24% in Mar 2025
Annual - Investments
Investments 3.50 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 1.74% vs 17.81% in Mar 2025
Annual - Current Assets
Current Assets 103.79 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 0.42% vs 0.77% in Mar 2025
